What to Expect When Starting Famotidine
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Famotidine (Pepcid) is an H2 receptor blocker that reduces stomach acid by blocking histamine H2 receptors on stomach cells. It is used for heartburn, GERD, gastric and duodenal ulcers, and Zollinger-Ellison syndrome. H2 blockers work faster than PPIs for occasional heartburn (within 30-60 minutes) but generally provide less acid suppression overall. Famotidine is available both over-the-counter (20 mg) and prescription (20-40 mg).
Week-by-week timeline
Rapid Heartburn Relief
Famotidine begins reducing acid within 1 hour and provides relief lasting 10-12 hours. For acid reflux taken twice daily, it provides morning and evening coverage. Unlike PPIs, famotidine can be taken at or near mealtime. Tolerance can develop over days to weeks with continuous use, which is one reason PPIs have displaced H2 blockers for GERD treatment.
Consistent Use for GERD or Ulcers
For GERD or ulcer treatment, famotidine is taken once or twice daily. Symptoms should be clearly improved. Tolerance (reduced response over time) can develop with continuous use — discuss with your prescriber if symptoms return despite consistent dosing.
Ulcer Healing Assessment
For duodenal ulcers, famotidine typically heals most ulcers within 4-8 weeks. For gastric ulcers, 8-12 weeks may be required. Complete the prescribed course even if symptoms resolve — symptom relief precedes complete healing.
Reassessment
Your prescriber should reassess the need for continued therapy. For occasional heartburn, famotidine as-needed may replace daily dosing. For GERD, lifestyle modifications alongside H2 blocker therapy should be optimized.
Maintenance or Step-Down
Long-term famotidine is generally well-tolerated with a better safety profile than PPIs for long-term use. Tolerance may mean a step up to a PPI is needed for inadequately controlled GERD. Reassess regularly.
When to call your doctor
Contact your healthcare provider if you experience:
- Persistent difficulty swallowing (dysphagia) — requires evaluation
- Unintentional weight loss with heartburn symptoms
- Vomiting blood or black/tarry stools (bleeding ulcer — seek emergency care)
- Persistent heartburn despite 2-4 weeks of famotidine therapy (may need endoscopy or PPI)
- Signs of allergic reaction: rash, swelling, difficulty breathing
- Confusion or agitation, especially in elderly patients or those with kidney disease (famotidine can cause CNS effects when renally impaired)
Tips for getting started
For best results with meal-related heartburn, take famotidine 15-60 minutes before the meal that triggers symptoms. For overnight reflux, take at bedtime. Famotidine can be taken with antacids for additive immediate relief. If you develop tolerance (symptoms returning), take a break from continuous use (if using for GERD long-term, discuss alternatives). Avoid foods and behaviors that trigger reflux: large meals, fatty/spicy foods, alcohol, lying down within 3 hours of eating, caffeine, and tobacco. Elevating the head of the bed 6-8 inches can significantly help nocturnal GERD.
Frequently asked questions
More about Famotidine
References
- [Regulatory] FDA Label: Pepcid (famotidine) Tablets https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/019462s033lbl.pdf Accessed 2026-03-01.
- [Regulatory] NIH MedlinePlus: Famotidine https://medlineplus.gov/druginfo/meds/a687011.html Accessed 2026-03-01.
- [Regulatory] ACG GERD Guidelines: H2 Receptor Antagonists https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907822/ Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: